Occupational asthma

Abramson, M.; Sim, M. R.
September 2006
Thorax;Sep2006, Vol. 61 Issue 9, p741
Academic Journal
The article discusses occupational asthma as the most common occupational lung disease in western countries. The disease is found to a contribution on the exposure to silica, asbestos, and coal dust. Its association on the kind of occupation that a person has, makes the diagnosis of the disease to be unsuccessful. In order for the diagnosis to be successful, clinicians have to get involved with the primary, secondary and tertiary prevention of occupational asthma.


Related Articles

  • An exploratory, pragmatic, cluster randomised trial of practice nurse training in the use of asthma action plans. Cleland, Jennifer A.; Hall, Susan; Price, David; Lee, Amanda J. // Primary Care Respiratory Journal;Oct2007, Vol. 16 Issue 5, p311 

    Introduction: To investigate the feasibility of improving asthma management - in particular, the implementation of individualised asthma action plans (AAPs) for poorly-controlled adult asthma patients - by providing training in asthma-focused clinical and communication skills for practice nurses...

  • Do you need to read this article? Try this quiz.  // New Zealand Doctor;11/19/2008, p19 

    A quiz about asthma diagnosis and treatment is presented.

  • Recognising dysfunctional breathing in asthma consultations. Henderson, Yvonne // Nursing Standard;9/26/2007, Vol. 22 Issue 3, p40 

    There is a high prevalence of dysfunctional breathing among patients diagnosed with asthma, so it is important that health professionals are aware of its effects. This article examines dysfunctional breathing and discusses diagnostic and possible treatment options.

  • Chronic Obstructive Pulmonary Disease in Women: Past and Future Challenges. Han, MeiLan K.; DeMeo, Dawn L.; Mannino, David M.; Ohar, Jill A. // Journal of Women's Health (15409996);2014Supplement-COPD in Women An Expert Panel Discussion, p1 

    The article discusses the highlights of a panel discussion which discussed practical suggestions for clinicians treating women with chronic obstructive pulmonary disease (COPD). Participants in the panel were Doctor (Dr.) Dawn DeMeo, Dr. David M Mannino and Dr. Jill A. Ohar who covered topics...

  • How asthma care is changing. Hall, Julie // Independent Nurse;8/4/2008, p27 

    The article features the recent innovations for the treatment of asthma in Great Britain. One of the recently made innovations includes the chloroflurocarbon (CFC)-containing preventers which require half-dose reduction due to particle size and are available as a breath-actuated product....

  • Diagnosis of Chronic Obstructive Pulmonary Disease. Stephens, Mark B.; Yew, Kenneth S. // American Family Physician;7/1/2008, Vol. 78 Issue 1, p87 

    Chronic obstructive pulmonary disease affects more than 26 million adults in the United States. Family physicians provide care for most of these patients. Cigarette smoking is the leading risk factor for chronic obstructive pulmonary disease, although other risk factors, including occupational...

  • Education: Clinical Review - Chronic obstructive pulmonary disease.  // GP: General Practitioner;1/20/2014, p10 

    The article offers information on chronic obstructive pulmonary disease (COPD). Topics discussed include the incidence of COPD in Great Britain, the signs and symptoms, diagnosis, and treatment for this disease. Also mentioned are pulmonary rehabilitation programmes that provide supervised...

  • Occupational asthma: Health crisis in health care workers.  // Occupational Health Management;Mar2007, Vol. 17 Issue 3, p25 

    Occupational asthma is a serious problem among health care workers, according to data available in states tracking the disease. • Sixteen percent of confirmed occupational asthma cases in four states were in health care workers. • Cleaning products are most often to blame for...

  • Is the 'blue' colour convention for inhaled reliever medications important? A UK-based survey of healthcare professionals and patients with airways disease. Fletcher, Monica; Scullion, Jane; White, John; Thompson, Bronwen; Capstick, Toby // Primary Care Respiratory Society UK;11/3/2016, p16081 

    In many countries, short-acting β2-agonist inhalers have traditionally been coloured blue. This inhaled therapy has also conventionally been known as a 'reliever' by patients and healthcare professionals (HCPs), in comparison with 'preventer' medications (inhaled steroids). With the rapidly...


Read the Article


Sign out of this library

Other Topics